192 related articles for article (PubMed ID: 20224052)
1. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
Revermann M; Schloss M; Barbosa-Sicard E; Mieth A; Liebner S; Morisseau C; Geisslinger G; Schermuly RT; Fleming I; Hammock BD; Brandes RP
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):909-14. PubMed ID: 20224052
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibition modulates vascular remodeling.
Simpkins AN; Rudic RD; Roy S; Tsai HJ; Hammock BD; Imig JD
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H795-806. PubMed ID: 20035028
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
6. Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Qin X; Wu Q; Lin L; Sun A; Liu S; Li X; Cao X; Gao T; Luo P; Zhu X; Wang X
Mol Neurobiol; 2015 Aug; 52(1):187-95. PubMed ID: 25128026
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
[TBL] [Abstract][Full Text] [Related]
9. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
[TBL] [Abstract][Full Text] [Related]
10. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
12. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.
Jiang JX; Guan Y; Shen HJ; Jia YL; Shen J; Zhang LH; Liu Q; Zhu YL; Xie QM
Eur J Pharmacol; 2020 Feb; 868():172874. PubMed ID: 31866410
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
Zhang LN; Vincelette J; Cheng Y; Mehra U; Chen D; Anandan SK; Gless R; Webb HK; Wang YX
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
[TBL] [Abstract][Full Text] [Related]
16. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.
Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
[TBL] [Abstract][Full Text] [Related]
18. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
